Dr Nirupama Verma

Senior Research Fellow
ANZAC Research Institute, Concord Clinical School

Telephone +61 2 9767 9884
Fax +61 2 9767 9101

Map

Selected grants

2014

  • EVOS FL Auto cell imaging system; Nicholson G, Clark G, Zhou H, Jessup W, Le Couteur D, McMahon A, McLachlan A, Allan C, Handelsman D, Hart D, Walters K, Kritharides L, Kockx M, Kennerson M, Cooper M, Seibel M, Verma N, Silveira P, Fromm P, Simanainen U, Cogger V, Zheng Y; National Health and Medical Research Council (NHMRC)/Equipment Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Verma, N., Hall, B., Plain, K., Robinson, C., Boyd, R., Tran, G., Wang, C., Bishop, A., Hodgkinson, S. (2014). Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients. Frontiers in Immunology, 5, 1-11. [More Information]
  • Plain, K., Verma, N., Tran, G., Nomura, M., Boyd, R., Robinson, C., Hodgkinson, S., Hall, B. (2013). Cytokines affecting CD4+ T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4+CD25+ Treg. Transplant Immunology, 29, 51-59. [More Information]
  • Hall, B., Tran, G., Verma, N., Plain, K., Robinson, C., Nomura, M., Hodgkinson, S. (2013). Do natural T regulatory cells become activated to antigen specific T regulatory cells in transplantation and in autoimmunity? Frontiers in Immunology, 4, 208. [More Information]
  • Tran, G., Hodgkinson, S., Carter, N., Verma, N., Plain, K., Boyd, R., Robinson, C., Nomura, M., Killingsworth, M., Hall, B. (2012). IL-5 promotes induction of antigen-specific CD4+CD25+T regulatory cells that suppress autoimmunity. Blood, 119(19), 4441-4450. [More Information]
  • Jeet, V., Russell, P., Verma, N., Khatri, A. (2012). Targeting aurora kinases: a novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer. Current Cancer Drug Targets, 12(2), 144-163. [More Information]
  • Hall, B., Verma, N., Tran, G., Hodgkinson, S. (2011). Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells. Current Opinion in Immunology, 23(5), 641-647. [More Information]
  • Singh, P., Joshi, S., Russell, P., Verma, N., Wang, X., Khatri, A. (2011). Molecular chemotherapy and chemotherapy: a new front against late-stage hormone-refractory prostate cancer. Clinical Cancer Research, 17(12), 4006-4018. [More Information]
  • Tran, G., Hodgkinson, S., Carter, N., Killingsworth, M., Nomura, M., Verma, N., Plain, K., Boyd, R., Hall, B. (2010). Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis. Journal of Neuroimmunology, 229(1-2), 98-106. [More Information]
  • Verma, N., Plain, K., Nomura, M., Tran, G., Robinson, C., Boyd, R., Hodgkinson, S., Hall, B. (2009). CD4+CD25+T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting seperate pathways of activation by Th1 and Th2 responses. Blood, 113(2), 479-487. [More Information]
  • Hall, B., Robinson, C., Plain, K., Verma, N., Carter, N., Boyd, R., Tran, G., Hodgkinson, S. (2008). Studies on naïve CD4+CD25+ T cell inhibition of naïve CD4+CD25- T cells in mixed lymphocyte culture. Transplant Immunology, 18(4), 291-301. [More Information]
  • Davidson, C., Verma, N., Robinson, C., Plain, K., Tran, G., Hodgkinson, S., Hall, B. (2007). IL-13 prolongs allograft survival: Association with inhibition of macrophage cytokine activation. Transplant Immunology, 17(3), 178-186.
  • Hall, B., Plain, K., Verma, N., Tran, G., Boyd, R., Robinson, C., Nicolls, M., Berger, M., Nomura, M., Hodgkinson, S. (2007). Transfer of allograft specific tolerance requires CD4+CD25 +T cells but not interleukin-4 or transforming growth factor-β and cannot induce tolerance to linked antigens. Transplantation, 83(8), 1075-1084.
  • Plain, K., Boyd, R., Verma, N., Robinson, C., Tran, G., Hodgkinson, S., Hall, B. (2007). Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-β blockade or Th1 cytokine administration. Transplantation, 83(6), 764-773.
  • Verma, N., Boyd, R., Robinson, C., Plain, K., Tran, G., Hall, B. (2006). Interleukin-12p70 Prolongs Allograft Survival by Induction of Interferon Gamma and Nitric Oxide Production. Transplantation, 82(10), 1324-1333.
  • Nomura, M., Plain, K., Verma, N., Robinson, C., Boyd, R., Hodgkinson, S., Hall, B. (2006). The cellular basis of cardiac allograft rejection. IX. Ratio of naive CD4+CD25+/CD4+CD25- T cells determines rejection or tolerance. Transplantation Proceedings, 15(4), 311-318.
  • Hall, B., Chen, J., Robinson, C., He, X., Plain, K., Verma, N., Hodgkinson, S. (2001). Conditioned dendritic cells as a temporal bridge between T helper and cytotoxic cells. Transplantation Proceedings, 33(1-2), 195-196.

Conferences

  • Verma, N., Tran, G., Hodgkinson, S., Plain, K., Bishop, A., Boyd, R., Robinson, C., Wang, C., Hall, B. (2011). IL-12p70 induces IL-2 alloactivated CD4+CD25+ Treg to Th1 like Treg that suppress fully allogeneic graft rejection. 41st Australasian Society for Immunology Annual Meeting, N/A: N/A.
  • Tran, G., Hodgkinson, S., Carter, N., Killingsworth, M., Nomura, M., Verma, N., Plain, K., Boyd, R., Robinson, C., Hall, B. (2011). IL-5 therapy prevents autoimmune demyelination by promotion of IL-4 activated antigen specific Treg. 41st Australasian Society for Immunology Annual Meeting, N/A: N/A.
  • Tran, G., Hodgkinson, S., Carter, N., Verma, N., Robinson, C., Plain, K., Boyd, R., Hall, B. (2011). In vitro induction of antigen specific CD4+CD25+ Tregulatory cells that prevent autoimmune mediated demyelination. 41st Australasian Society for Immunology Annual Meeting, N/A: N/A.
  • Verma, N., Plain, K., Nomura, M., Tran, G., Robinson, C., Boyd, R., Hodgkinson, S., Hall, B. (2008). IL-2 or IL-4 activated CD4+CD25+T cells in MLC become antigen specific and respectively express IFN-y receptor (R) or IL-5Ra. Keystone Symposia conference "Tolerance in transplantation and Autoimmunity", Colorado, USA: Keystone Symposia.
  • Boyd, R., Hodgkinson, S., Carter, N., Tran, G., Plain, K., Verma, N., Robinson, C., Hall, B. (2007). Absence of membrane attack complex (MAC), delays onset of proteinuria in heymann nephritis (HN). 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Blackwell Synergy.
  • Verma, N., Plain, K., Tran, G., Boyd, R., Hodgkinson, S., Carter, N., Robinson, C., Hall, B. (2007). Allograft tolerance mediating CD4+T cells depend upon interferon- gamma (IFN-g) or interleukin-5 (IL-5). 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Blackwell Synergy.
  • Boyd, R., Hodgkinson, S., Carter, N., Tran, G., Plain, K., Verma, N., Robinson, C., Hall, B. (2007). Complement C6 deficiency in Lewis rats does not prevent proteinuria in active Heymann Nephritis. American Society of Nephrology Renal Week 2007, USA: American Society of Nephrology.
  • Verma, N., Plain, K., Robinson, C., Boyd, R., Tran, G., Carter, N., Hodgkinson, S., Hall, B. (2007). Th1 and Th2 responses induce separate lineages of CD4+CD25+T cells that mediate allograft tolerance. 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Blackwell Synergy.
  • Hall, B., Plain, K., Robinson, C., Nomura, M., Verma, N., Boyd, R., Tran, G., Hodgkinson, S. (2006). A test to detect specific immune tolerance to transplanted organs by examining in vitro reactivity of peripheral CD4+ T cells and the CD25+ and CD25- subsets. World Transplant Congress 2006, USA: Blackwell Publishers.
  • Verma, N., Plain, K., Nomura, M., Tran, G., Robinson, C., Boyd, R., Hodgkinson, S., Hall, B. (2006). CD4+CD25+ T suppressor cells induced by short-term culture with IL-2 or IL-4 and specific alloantigen have increased specific suppressive capacity both in vitro and in vivo. World Transplant Congress 2006, USA: Blackwell Publishers.
  • Plain, K., Verma, N., Tran, G., Boyd, R., Nomura, M., Robinson, C., Hodgkinson, S., Hall, B. (2006). IL-4 does not maintain specific tolerance mediating CD4+CD25+ T suppressor cells but induces antigen-specific naive CD4+CD25+ T cells. World Transplant Congress 2006, USA: Blackwell Publishers.
  • Hodgkinson, S., Nomura, M., Tran, G., Verma, N., Plain, K., Boyd, R., Hall, B. (2006). Transplant tolerance mediating CD4+ T cells contain CD4+CD25+ T cells that express interferon-gamma receptor and their survival is promoted by IFN-gamma. World Transplant Congress 2006, USA: Blackwell Publishers.
  • Plain, K., Verma, N., Boyd,, R., Tran, G., Carter, N., Hodgkinson, S. (2005). IFN-y receptor and IL-4 receptor expression on CD4+,CD25+ regulatory T cells. Transplantation Society of Australia.
  • Plain, K., Robinson, C., Boyd, R., Verma, N., Tran, G., Hodgkinson, S., Hall, B. (2002). IL-4 does not maintain the function of specific CD4+,CD25+ regulatory T cells in allograft tolerance. Australian Society of Health and Medical Research.

2014

  • Verma, N., Hall, B., Plain, K., Robinson, C., Boyd, R., Tran, G., Wang, C., Bishop, A., Hodgkinson, S. (2014). Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients. Frontiers in Immunology, 5, 1-11. [More Information]

2013

  • Plain, K., Verma, N., Tran, G., Nomura, M., Boyd, R., Robinson, C., Hodgkinson, S., Hall, B. (2013). Cytokines affecting CD4+ T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4+CD25+ Treg. Transplant Immunology, 29, 51-59. [More Information]
  • Hall, B., Tran, G., Verma, N., Plain, K., Robinson, C., Nomura, M., Hodgkinson, S. (2013). Do natural T regulatory cells become activated to antigen specific T regulatory cells in transplantation and in autoimmunity? Frontiers in Immunology, 4, 208. [More Information]

2012

  • Tran, G., Hodgkinson, S., Carter, N., Verma, N., Plain, K., Boyd, R., Robinson, C., Nomura, M., Killingsworth, M., Hall, B. (2012). IL-5 promotes induction of antigen-specific CD4+CD25+T regulatory cells that suppress autoimmunity. Blood, 119(19), 4441-4450. [More Information]
  • Jeet, V., Russell, P., Verma, N., Khatri, A. (2012). Targeting aurora kinases: a novel approach to curb the growth & chemoresistance of androgen refractory prostate cancer. Current Cancer Drug Targets, 12(2), 144-163. [More Information]

2011

  • Hall, B., Verma, N., Tran, G., Hodgkinson, S. (2011). Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells. Current Opinion in Immunology, 23(5), 641-647. [More Information]
  • Verma, N., Tran, G., Hodgkinson, S., Plain, K., Bishop, A., Boyd, R., Robinson, C., Wang, C., Hall, B. (2011). IL-12p70 induces IL-2 alloactivated CD4+CD25+ Treg to Th1 like Treg that suppress fully allogeneic graft rejection. 41st Australasian Society for Immunology Annual Meeting, N/A: N/A.
  • Tran, G., Hodgkinson, S., Carter, N., Killingsworth, M., Nomura, M., Verma, N., Plain, K., Boyd, R., Robinson, C., Hall, B. (2011). IL-5 therapy prevents autoimmune demyelination by promotion of IL-4 activated antigen specific Treg. 41st Australasian Society for Immunology Annual Meeting, N/A: N/A.
  • Tran, G., Hodgkinson, S., Carter, N., Verma, N., Robinson, C., Plain, K., Boyd, R., Hall, B. (2011). In vitro induction of antigen specific CD4+CD25+ Tregulatory cells that prevent autoimmune mediated demyelination. 41st Australasian Society for Immunology Annual Meeting, N/A: N/A.
  • Singh, P., Joshi, S., Russell, P., Verma, N., Wang, X., Khatri, A. (2011). Molecular chemotherapy and chemotherapy: a new front against late-stage hormone-refractory prostate cancer. Clinical Cancer Research, 17(12), 4006-4018. [More Information]

2010

  • Tran, G., Hodgkinson, S., Carter, N., Killingsworth, M., Nomura, M., Verma, N., Plain, K., Boyd, R., Hall, B. (2010). Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis. Journal of Neuroimmunology, 229(1-2), 98-106. [More Information]

2009

  • Verma, N., Plain, K., Nomura, M., Tran, G., Robinson, C., Boyd, R., Hodgkinson, S., Hall, B. (2009). CD4+CD25+T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting seperate pathways of activation by Th1 and Th2 responses. Blood, 113(2), 479-487. [More Information]

2008

  • Verma, N., Plain, K., Nomura, M., Tran, G., Robinson, C., Boyd, R., Hodgkinson, S., Hall, B. (2008). IL-2 or IL-4 activated CD4+CD25+T cells in MLC become antigen specific and respectively express IFN-y receptor (R) or IL-5Ra. Keystone Symposia conference "Tolerance in transplantation and Autoimmunity", Colorado, USA: Keystone Symposia.
  • Hall, B., Robinson, C., Plain, K., Verma, N., Carter, N., Boyd, R., Tran, G., Hodgkinson, S. (2008). Studies on naïve CD4+CD25+ T cell inhibition of naïve CD4+CD25- T cells in mixed lymphocyte culture. Transplant Immunology, 18(4), 291-301. [More Information]

2007

  • Boyd, R., Hodgkinson, S., Carter, N., Tran, G., Plain, K., Verma, N., Robinson, C., Hall, B. (2007). Absence of membrane attack complex (MAC), delays onset of proteinuria in heymann nephritis (HN). 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Blackwell Synergy.
  • Verma, N., Plain, K., Tran, G., Boyd, R., Hodgkinson, S., Carter, N., Robinson, C., Hall, B. (2007). Allograft tolerance mediating CD4+T cells depend upon interferon- gamma (IFN-g) or interleukin-5 (IL-5). 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Blackwell Synergy.
  • Boyd, R., Hodgkinson, S., Carter, N., Tran, G., Plain, K., Verma, N., Robinson, C., Hall, B. (2007). Complement C6 deficiency in Lewis rats does not prevent proteinuria in active Heymann Nephritis. American Society of Nephrology Renal Week 2007, USA: American Society of Nephrology.
  • Davidson, C., Verma, N., Robinson, C., Plain, K., Tran, G., Hodgkinson, S., Hall, B. (2007). IL-13 prolongs allograft survival: Association with inhibition of macrophage cytokine activation. Transplant Immunology, 17(3), 178-186.
  • Verma, N., Plain, K., Robinson, C., Boyd, R., Tran, G., Carter, N., Hodgkinson, S., Hall, B. (2007). Th1 and Th2 responses induce separate lineages of CD4+CD25+T cells that mediate allograft tolerance. 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. Blackwell Synergy.
  • Hall, B., Plain, K., Verma, N., Tran, G., Boyd, R., Robinson, C., Nicolls, M., Berger, M., Nomura, M., Hodgkinson, S. (2007). Transfer of allograft specific tolerance requires CD4+CD25 +T cells but not interleukin-4 or transforming growth factor-β and cannot induce tolerance to linked antigens. Transplantation, 83(8), 1075-1084.
  • Plain, K., Boyd, R., Verma, N., Robinson, C., Tran, G., Hodgkinson, S., Hall, B. (2007). Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-β blockade or Th1 cytokine administration. Transplantation, 83(6), 764-773.

2006

  • Hall, B., Plain, K., Robinson, C., Nomura, M., Verma, N., Boyd, R., Tran, G., Hodgkinson, S. (2006). A test to detect specific immune tolerance to transplanted organs by examining in vitro reactivity of peripheral CD4+ T cells and the CD25+ and CD25- subsets. World Transplant Congress 2006, USA: Blackwell Publishers.
  • Verma, N., Plain, K., Nomura, M., Tran, G., Robinson, C., Boyd, R., Hodgkinson, S., Hall, B. (2006). CD4+CD25+ T suppressor cells induced by short-term culture with IL-2 or IL-4 and specific alloantigen have increased specific suppressive capacity both in vitro and in vivo. World Transplant Congress 2006, USA: Blackwell Publishers.
  • Plain, K., Verma, N., Tran, G., Boyd, R., Nomura, M., Robinson, C., Hodgkinson, S., Hall, B. (2006). IL-4 does not maintain specific tolerance mediating CD4+CD25+ T suppressor cells but induces antigen-specific naive CD4+CD25+ T cells. World Transplant Congress 2006, USA: Blackwell Publishers.
  • Verma, N., Boyd, R., Robinson, C., Plain, K., Tran, G., Hall, B. (2006). Interleukin-12p70 Prolongs Allograft Survival by Induction of Interferon Gamma and Nitric Oxide Production. Transplantation, 82(10), 1324-1333.
  • Nomura, M., Plain, K., Verma, N., Robinson, C., Boyd, R., Hodgkinson, S., Hall, B. (2006). The cellular basis of cardiac allograft rejection. IX. Ratio of naive CD4+CD25+/CD4+CD25- T cells determines rejection or tolerance. Transplantation Proceedings, 15(4), 311-318.
  • Hodgkinson, S., Nomura, M., Tran, G., Verma, N., Plain, K., Boyd, R., Hall, B. (2006). Transplant tolerance mediating CD4+ T cells contain CD4+CD25+ T cells that express interferon-gamma receptor and their survival is promoted by IFN-gamma. World Transplant Congress 2006, USA: Blackwell Publishers.

2005

  • Plain, K., Verma, N., Boyd,, R., Tran, G., Carter, N., Hodgkinson, S. (2005). IFN-y receptor and IL-4 receptor expression on CD4+,CD25+ regulatory T cells. Transplantation Society of Australia.

2002

  • Plain, K., Robinson, C., Boyd, R., Verma, N., Tran, G., Hodgkinson, S., Hall, B. (2002). IL-4 does not maintain the function of specific CD4+,CD25+ regulatory T cells in allograft tolerance. Australian Society of Health and Medical Research.

2001

  • Hall, B., Chen, J., Robinson, C., He, X., Plain, K., Verma, N., Hodgkinson, S. (2001). Conditioned dendritic cells as a temporal bridge between T helper and cytotoxic cells. Transplantation Proceedings, 33(1-2), 195-196.

To update your profile click here. For support on your academic profile contact .